Chronic myeloid leukemia originates from hematopoietic stem cells acquiring the BCR-ABL fusion gene, which encodes a tyrosine kinase with consecutive activity. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.